Philips Introduces New SpeechExec Enterprise Dictation and Transcription Software
Speech Processing Solutions, the world number one in professional dictation, announced their latest speech-to-text software Philips SpeechExec Enterprise. The new sophisticated workflow management software allows busy healthcare, legal and business professionals to streamline their document creation process and significantly reduce their workload.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180417005035/en/
Philips SpeechExec Enterprise
Smarter communication and convenient central administration
The dictation and transcription software facilitates communication by linking authors and transcriptionists. Whether the user works in a hospital, or a legal practice, the software is ideal for turning their voice into text quicker, and more efficiently than ever before. Dr. Thomas Brauner, CEO of Speech Processing Solutions explains: “Philips SpeechExec Enterprise is perfect for larger organizations with multiple authors and transcriptionists, as it can easily be centrally administrated and maintained.” All workflow settings, as well as the hardware input devices, can be centrally administrated and configured. The solution is also Microsoft Remote Desktop Services (RDS), Citrix and VMware ready, making the installation process easier and more convenient for both users and IT administrators.
Full mobility for increased productivity
The new version of Philips’ SpeechExec Enterprise offers full mobility, meaning recordings can created anywhere and sent for transcription immediately. Even if the user is out of the office, they can download the brand-new Philips Voice Recorder App to their smartphone and send their recordings directly to their assigned transcriptionists.
Geared for on the go speech recognition
The software now even works seamlessly with Philips SpeechLive transcription and speech recognition service, allowing users to receive their transcribed files directly to their smartphone or Philips SpeechAir Voice Recorder. Another new mobility enhancing feature is that dictations can now even be accessed through a web browser. This can be particularly useful when an individual wants to use their solution on a business trip, without access to their standard computer.
Secure file transfer
Real-time file encryption (256 bit), password protection and secure file transfer grant only authorized individuals to access documents. The optional automatic backup function protects data against accidental loss. Dr. Brauner explains: “We know exactly how important security is to our customers working with sensitive data, such as patient records or legal cases. This is why our software adheres to the highest of security standards and we now even offer support for your private cloud environment“.
To find out more about the new software, visit: www.philips.com/dictation
Download the Philips Voice Recorder App now: https://www.dictation.philips.com/products/mobile-dictation/voice-recorder-app-lfh7400/
About Speech Processing Solutions
Speech Processing Solutions is the global number one in professional dictation solutions. Founded in Austria in 1954 as part of Philips, the company has been the driving force behind innovative speech-to-text solutions for over 60 years. The company has developed ground-breaking products, such as the mobile Philips SpeechAir device, the Philips PocketMemo voice recorder, the Philips SpeechMike Premium USB dictation microphone and the Philips voice recorder app for smartphones, thus delivering its promise of excellence and outstanding quality. Thanks to the latest innovation, Philips SpeechLive, designed as a cloud-based workflow solution, recording dictations is quicker and easier than ever. The tailored range of products and services offered by Speech Processing Solutions helps professional users to save time and resources and to work at maximum efficiency.
Follow Speech Processing Solutions:
Twitter @speech_com: http://www.twitter.com/speech_com
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Overseas Roadshow for the IAPH Guangzhou 2019 World Ports Conference Was Held in London21.9.2018 03:08 | Pressemelding
Overseas roadshow for the IAPH Guangzhou 2019 World Ports Conference was successfully held in Armourer's Hall, London, UK on September 20th. Ms. Yuan Yue, Deputy Director General of Guangzhou Port Authority, met with over 100 senior representatives from British ports, ship-owners, commodity traders, shipping & service companies, shipping public policy research institutes, and other representatives from the port and shipping industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006031/en/ Speech made by Lord Jeffrey Evans, Chairman of Maritime London (Photo: Business Wire) In her keynote speech, Ms. Yuan Yue said, “Guangzhou is the gateway city of South China and is known as the “Millennium Business Capital” and a popular destination for business and investment. At present, Guangzhou has attracted investors from over 130 countries. Nearly 300 of the world's top 500 companies have businesses and investment in Guangzho
AbuDhabi Dubai STOB Series 22 Investment Enters into Favorable Tender Offer Agreement with MINDOL HOLDINGS21.9.2018 01:00 | Pressemelding
AbuDhabi Dubai STOB Series 22 Investment Limited Partnership, hereafter AbuDhabi22, and MINDOL HOLDINGS LIMITED, hereafter MINDOL, listed on the Hong Kong-based Coinsuper exchange (https://www.coinsuper.com) have reached an agreement where AbuDhabi22 will acquire the minimum 33.3 percent holding for the MINDOL cryptocurrency (MIN, https://mindol.net) to be issued by MINDOL, via a tender offer (TOB). Implementation of the TOB will serve to strengthen the strategic partnership with MINDOL. Both companies expect that the AbuDhabi22 bid will greatly exceed any bids made via ordinary exchange channels. With a bid offering at a stable price, the TOB method was chosen for its strategic worth. The MINDOL business vision for 2019 sets a target for its cryptocurrency, from among the more than 2,000 types of cryptocurrencies currently available, to have a top-30 market capitalization. As a business that focuses on "the fusion of subculture and blockchain," they will develop an online game that ta
Afton Chemical’s S$380 Million Phase II Expansion of Its Jurong Island Plant is Now Complete20.9.2018 21:07 | Pressemelding
Afton Chemical Corporation, a global leader in the lubricant and fuel additive market, today announced the completion of the Phase II expansion of its Chemical Additive Manufacturing Facility in Jurong Island, Singapore. This milestone was marked by a special visit from Singapore’s Minister for Trade & Industry Mr. Chan Chun Sing, who also made a speech and toured the facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920005903/en/ Afton Chemical Corporation – Singapore Chemical Additive Manufacturing Facility Phase II Expansion (Photo: Business Wire) As a wholly owned subsidiary of NewMarket Corporation (NYSE: NEU), Afton has been a leading player in the lubricant and fuel additive marketplace for over 90 years. The company was founded on a Passion for Solutions® and has maintained a focus on customizing commercial and industrial solutions that meet customer needs. Afton begun its Singapore manufacturing operations
IFF Announces Pricing of €1,100,000,000 Senior Notes Offering20.9.2018 20:15 | Pressemelding
Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF), a leading innovator of sensorial experiences that move the world, today announced that it has priced its public offering of €300,000,000 aggregate principal amount of its 0.500% senior notes due 2021 and €800,000,000 aggregate principal amount of its 1.800% senior notes due 2026. IFF intends to use the net proceeds from the offering to pay a portion of the consideration for the previously announced merger with Frutarom Industries Ltd. and to pay related fees and expenses. IFF anticipates that the offering will close on September 25, 2018, subject to customary closing conditions. The offering is not contingent upon the consummation of the merger. If the closing of the merger has not occurred on or prior to February 7, 2019, or, if prior to such date, the merger agreement with Frutarom is terminated, IFF will be required to redeem all of the notes on the special mandatory redemption date at a redem
Bentall Kennedy Ranked 1st in Canada, 2nd Globally in the 2018 Global Real Estate Sustainability Benchmark (GRESB) Rankings20.9.2018 20:00 | Pressemelding
For the eighth consecutive year, the Global Real Estate Sustainability Benchmark (GRESB) has ranked Bentall Kennedy among the top firms in the world for its commitment to investing sustainably. Bentall Kennedy retained its position as a top global leader in sustainability on the strength of its collaboration with clients and tenants, and its employees’ commitment to driving innovation in asset and property management. For 2018, Bentall Kennedy ranked as the top firm in Canada and the 2nd globally among diversified firms. In addition, MEPT/MEPT Edgemoor LP, the U.S. core open end fund strategy advised by Bentall Kennedy, continues to be ranked top 3 globally in its category (Global – Diversified). The 2018 GRESB survey included 903 entities (+6% from 2017) covering 79,000 assets with an aggregate value of USD $3.7 trillion. "Given the increased competition globally, we are extremely proud that the most recent GRESB results continue to demonstrate Bentall Kennedy’s worldwide leadership p
Pierre Fabre Receives EU Approval for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) in Adult Patients with Advanced BRAF-Mutant Melanoma20.9.2018 17:21 | Pressemelding
Pierre Fabre today announced that the European Commission (EC) has granted marketing authorisation for the combination of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation, as detected by a validated test.1,2 The EC decision is applicable to all 28 European Union (EU) member states plus Liechtenstein, Iceland and Norway. "We are extremely pleased that European patients with advanced BRAF-mutant melanoma will now have the combination of BRAFTOVI and MEKTOVI as a new treatment option”, said Frédéric Duchesne, President & CEO of the Pierre Fabre Pharmaceuticals Division. “All of us at Pierre Fabre are driven to make a real difference for patients. Bringing more than 30 years of oncology experience and our heritage in dermatology to our partnership with Array BioPharma, we have been able to harness our expertise in order to help men and women living with this devastating disease. Today’s